Low Incidence of Chest Wall Pain with a Risk-Adapted Lung Stereotactic Body Radiation Therapy Approach Using Three or Five Fractions Based on Chest Wall Dosimetry

• Thibaud P. Coroller ,

  Contributed equally to this work with: Thibaud P. Coroller, Raymond H. Mak

  Affiliations Department of Radiation Oncology, Dana-Farber Cancer Institute/Brigham and Women's Hospital, Boston, Massachusetts, United States of America, Department of Radiation Oncology, Harvard Medical School, Boston, Massachusetts, United States of America, Joseph Fourier University, Department of Engineering for Health and Medicine, Grenoble, France

  ⨯
• Raymond H. Mak ,

  Contributed equally to this work with: Thibaud P. Coroller, Raymond H. Mak

  Affiliations Department of Radiation Oncology, Dana-Farber Cancer Institute/Brigham and Women's Hospital, Boston, Massachusetts, United States of America, Department of Radiation Oncology, Harvard Medical School, Boston, Massachusetts, United States of America

  ⨯
• John H. Lewis,

  Affiliations Department of Radiation Oncology, Dana-Farber Cancer Institute/Brigham and Women's Hospital, Boston, Massachusetts, United States of America, Department of Radiation Oncology, Harvard Medical School, Boston, Massachusetts, United States of America

  ⨯
• Elizabeth H. Baldini,

  Affiliations Department of Radiation Oncology, Dana-Farber Cancer Institute/Brigham and Women's Hospital, Boston, Massachusetts, United States of America, Department of Radiation Oncology, Harvard Medical School, Boston, Massachusetts, United States of America

  ⨯
• Aileen B. Chen,

  Affiliations Department of Radiation Oncology, Dana-Farber Cancer Institute/Brigham and Women's Hospital, Boston, Massachusetts, United States of America, Department of Radiation Oncology, Harvard Medical School, Boston, Massachusetts, United States of America

  ⨯
• Yolonda L. Colson,

  Affiliations Division of Thoracic Surgery, Brigham and Women's Hospital, Boston, Massachusetts, United States of America, Department of Radiation Oncology, Harvard Medical School, Boston, Massachusetts, United States of America

  ⨯
• Fred L. Hacker,

  Affiliations Department of Radiation Oncology, Dana-Farber Cancer Institute/Brigham and Women's Hospital, Boston, Massachusetts, United States of America, Department of Radiation Oncology, Harvard Medical School, Boston, Massachusetts, United States of America

  ⨯
• Gretchen Hermann,

  Affiliation Department of Radiation Oncology, Dana-Farber Cancer Institute/Brigham and Women's Hospital, Boston, Massachusetts, United States of America

  ⨯
• David Kozono,

  Affiliations Department of Radiation Oncology, Dana-Farber Cancer Institute/Brigham and Women's Hospital, Boston, Massachusetts, United States of America, Department of Radiation Oncology, Harvard Medical School, Boston, Massachusetts, United States of America

  ⨯
• Edward Mannarino,

  Affiliation Department of Radiation Oncology, Dana-Farber Cancer Institute/Brigham and Women's Hospital, Boston, Massachusetts, United States of America

  ⨯
• Christina Molodowitch,

  Affiliation Department of Radiation Oncology, Dana-Farber Cancer Institute/Brigham and Women's Hospital, Boston, Massachusetts, United States of America

  ⨯
• Jon O. Wee,

  Affiliations Division of Thoracic Surgery, Brigham and Women's Hospital, Boston, Massachusetts, United States of America, Department of Radiation Oncology, Harvard Medical School, Boston, Massachusetts, United States of America

  ⨯
• David J. Sher,

  Affiliation Department of Radiation Oncology, Rush University Medical Center, Chicago, Illinois, United States of America

  ⨯
• Joseph H. Killoran

  * E-mail: jkilloran@lroc.harvard.edu

  Affiliations Department of Radiation Oncology, Dana-Farber Cancer Institute/Brigham and Women's Hospital, Boston, Massachusetts, United States of America, Department of Radiation Oncology, Harvard Medical School, Boston, Massachusetts, United States of America

  ⨯